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Abstract
Background: Cleidocranial dysplasia (CCD) is a rare hereditary disorder that arises from heterozygous loss of
function mutations in the runt-related transcription factor 2 (RUNX2) gene. As RUNX2 is mainly expressed in
osteoblasts, CCD typically affects the skeletal and dental systems. Few studies have investigated RUNX2 mutation
effects on non-skeletal systems. Here, we describe limb-girdle myopathy, an uncommon phenotype of CCD, in a
patient with a heterozygous missense mutation (p.R225Q) in the RUNX2 gene.
Case presentation: A 58 year-old man presented with progressive back pain and six months of weakness in the
proximal parts of all four limbs. Physical examinations showed that he was short in stature (height, 164.4 cm;
weight, 79.1 kg) with a dysmorphic face, including hypertelorism, midface hypoplasia, and chin protrusion. At a
young age, he had received orthodontic surgery, due to dental abnormalities. Neurological examinations revealed
sloping shoulders, weakness, and atrophy in the proximal areas of the arms, shoulder girdle muscles, and legs. The
deep tendon reflex and sensory system were normal. Radiological examinations revealed mild scoliosis, shortened
clavicles, and a depressed skull bone, which were consistent with a clinical diagnosis of CCD. Electromyography
(EMG) studies showed myogenic polyphasic waves in the deltoid, biceps brachii, and rectus femoris muscles.
Instead, the EMG findings were normal in the first dorsal interosseous, tibialis anterior and facial muscles. The EMG
findings were compatible with a limb-girdle pattern with facial sparing. The patient’s family history showed his
father and eldest daughter with similar dysmorphic faces, skeletal disorders and proximal upper extremity weakness.
We sequenced the RUNX2 gene and discovered a heterozygous missense mutation (c.G674A, p.R225Q), which
altered the C-terminal end of the RUNX2 protein. This mutation was predicted to inactivate the protein and might
affect its interactions with other proteins. This mutation co-segregated with the disease phenotypes in the family.
Conclusions: We described limb-girdle myopathy in a patient with CCD that carried a heterozygous RUNX2
missense mutation. This uncommon phenotype expanded the phenotypic spectrum of the RUNX2 p.R225Q
mutation. The role of RUNX2 in myogenic development merits future studies. Our findings remind clinicians that
myopathic patients with myopathies combined with facial dysmorphism and shortened clavicles should consider
the diagnosis of CCD.
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Background
Cleidocranial dysplasia (CCD, OMIM 119600) is a rare
skeletal disorder of autosomal dominant inheritance
with an estimated incidence of 1/1,000,000 [1]. The main
clinical features of CCD include persistent, open cranial
sutures with bulging calvaria; hypoplasia or aplasia of
the clavicles; dental anomalies; a short middle phalanx
in the fifth finger; and associated vertebral anomalies [2].
This condition is primarily caused by mutations in the
gene that encodes runt-related transcription factor 2
(RUNX2, MIM #600211), located on chromosome 6p21
[3]. The RUNX2 gene encodes a 521 amino-acid protein
with a highly conserved region of 128 amino acids (runt
domain), an N-terminal stretch of glutamine/alanine re-
peats (Q/A domain), and a C-terminal proline/serine/
threonine-rich (PST) domain [2]. The RUNX2 protein
functions mainly in osteoblast differentiation and regula-
tion [4], which contributes to the skeletal and dental
abnormalities observed in CCD. In addition to its ex-
pression in osteoblasts, the RUNX2 protein is also
present in non-osteoblast cells, including skeletal and
smooth muscle cells [5], T cells [6], sperm cells, and
neurons [7]. However, few patients with CCD manifest
extra-skeletal manifestations. Here, we describe limb-
girdle myopathy, an uncommon phenotype in CCD, in a
patient with a heterozygous missense mutation in the
RUNX2 gene.
Case presentation
We examined a 58-year-old man with no underlying
medical conditions. He presented with progressive back
pain and 6 months of weakness in the proximal parts of
all four limbs. There was no diplopia, chocking, swallow-
ing difficulty, drop neck, respiratory distress or other
symptoms of heart failure while tracing back his history.
Physical examinations showed he was short in stature,
with a height of 164.4 cm and a weight of 79.1 kg. He
had a dysmorphic face with hypertelorism, midface hy-
poplasia, and chin protrusion (Fig. 1a). He had received
orthodontic surgery due to dental abnormalities while
he was young. Neurological examinations revealed slop-
ing shoulders, atrophy of the shoulder girdle muscles,
Fig. 1 Clinical pictures and radiologic findings for the index patient with CCD. a The photographs show a flat face, sunken nasal bridge,
hypertelorism, chin protrusion, and sloping shoulders. Arrows indicate atrophy of bilateral shoulder girdle muscles. b Chest X-ray shows the
absent right clavicle (arrow) and a hypoplastic left clavicle. c Skull X-ray shows wormian bones in the skull (left panel) and a hypoplastic maxilla
(right panel). d Spine X-ray reveals mild scoliosis of the thoraco-lumbar spine
Hsueh et al. BMC Neurology  (2017) 17:2 Page 2 of 6
and symmetrical weakness in the proximal parts of the
arms and legs. There was no facial weakness or limita-
tion of extra-ocular movement. The deep tendon reflex
and sensory systems were normal. Radiological examina-
tions revealed wormian bones in the skull, the absence
of the right clavicle, hypoplasia of the left clavicle, and
mild scoliosis. These signs were consistent with the clin-
ical diagnosis of CCD (Fig. 1b–d). Electromyography
(EMG) revealed myogenic polyphasic waves of small
amplitude and short-duration polyphasic waves at 400–
500 μV in the bilateral biceps brachii, deltoid, infraspina-
tus, trapezius, and rectus femoris muscles. However, the
EMG findings were normal in bilateral first dorsal inter-
osseous, tibialis anterior and facial muscles. Magnetic
resonance imaging (MRI) of the upper extremity showed
atrophy associated with fatty infiltration of right deltoid
and biceps brachii muscles without acute edematous
changes, suggesting a chronic muscle insult (Fig. 2a, b).
These findings indicated a limb-girdle distribution of
chronic myopathy. Laboratory data, including the serum
creatine kinase level, were normal. The thyroid function,
tumor markers, and autoimmune profiles for survey of
common metabolic and inflammatory myopathy were
within normal limits. Muscle biopsy of right biceps bra-
chii muscle was suggested but this suggestion was de-
clined by the patient. The patient did not have
symptoms of respiratory distress or heart failure sign.
Cardiac echo showed normal cardiac contractility and
the heart ejection fraction is within normal limits. The
patient’s family history showed that his father and eldest
daughter had similar skeletal, dental disorders and prox-
imal weakness of upper extremity (Fig. 3a). EMG find-
ings of bilateral deltoid, biceps brachii and rectus
femoris muscles of the proband’s elder daughter also
showed myopathic polyphasic waves. These observations
suggest that the myopathy is not a sporadic condition
associate with the patient but segregate with the skeletal
problems within his family.
The patient initially presented with facial dysmorph-
ism, sloping shoulders, atrophy, and weakness, pre-
dominantly over the shoulder girdle. Therefore, we
analyzed the double homeobox DUX4 gene for facios-
capulohumeral muscular dystrophy. In addition, the
radiologic findings and the patient’s autosomal-
dominant family history were consistent with CCD.
Therefore, we also analyzed the RUNX2 gene after
the patient provided informed consent. Genomic
DNA was extracted from peripheral whole blood for
PCR analysis. We amplified exons 1 through 8 and
the flanking intronic sequences of the RUNX2 gene
with eight pairs of PCR primers, designed as previ-
ously described [8]. Genetic analysis for the DUX4
gene was performed as previously described [9]. The
purified PCR products were sequenced in both direc-
tions at our on-site biochemistry sequencing facility
with Big Dye Version 3.1 and a 3730 XL sequencer
(Applied Biosystems, Foster City, CA). We found that
the patient carried a heterozygous missense mutation
(c.G674A, p.R225Q), located at the C-terminal end of
the RUNX2 protein. This mutation was predicted to
inactivate the protein, and it might also affect protein
structural stability and interactions with other pro-
teins. The reference sequence and base-pair numbers
refer to GenBank accession numbers AF001443-
AF001450 and NM_001024630. This mutation co-
segregated with the disease phenotype in the patient’s
family (Fig. 3B). Research protocol was reviewed by
the institutional ethics board committee of the National
Taiwan University Hospital and all subjects gave informed
consent.
Fig. 2 MRI of right upper extremity of the index patient. a Coronal T1 weighted MRI shows atrophy and fatty infiltration of the deltoid (arrow),
and biceps brachii (arrowhead) muscles. b Sagittal T1 weighted MRI displays concomitant atrophy and fatty infiltration of the trapezius (arrows)
and biceps brachii (arrowhead) muscles
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Conclusions
To date, variable RUNX2 mutations have been described
in subjects with CCD, including insertions, deletions,
nonsense, and missense mutations. CCD has been re-
ported in people of Mongoloid ethnicity, including Japa-
nese, Korean, Chinese, and Taiwanese [10–13]. In most
cases, patients present with classical skeletal and dental
abnormalities that appear in childhood. Here, we de-
scribed a patient with CCD that exhibited an uncommon
initial manifestation of late-onset, limb-girdle myopathy,
due to a missense mutation (c.G674A, p.R225Q) in the
RUNX2 gene.
The missense mutation, p.R225Q, located at the C-
terminal end of the runt domain, is a known mutational
hotspot in the RUNX2 gene [14, 15]. The runt domain is
a highly conserved DNA-binding domain, which binds
to a consensus DNA sequence. The runt domain also
mediates binding to CBFβ, an unrelated partner protein
that does not interact directly with DNA, but enhances
the DNA-binding affinity of the RUNX protein [16]. In
our patient, the substitution of Arg225 with glutamine
abolished the positive charge of the protein at this pos-
ition, which was predicted to impair the DNA binding
ability of RUNX2 [15]. Therefore, the p.R225Q mutation
can cause severe phenotypes in CCD.
The p.R225Q mutation was previously reported in a
Taiwanese patient with sporadic CCD. The age of onset
was 8 years old, and the patient presented with classical
bone phenotypes that had appeared in childhood [10].
This mutation was later reported in a teenage Korean
patient with sporadic CCD, who also presented with
dental and skeletal problems [11]. Those carriers of the
RUNX2 p.R225Q mutation reported no neurological
complaints; in particular, there were no symptoms or
signs of myopathy. In addition, a nearby nucleotide mis-
sense mutation, which changed the same amino acid,
c.C673T (p.R225W), was previously described in one
Italian family, but no atypical features were reported
[17]. Those observations reinforced the notion that
Arg225 played a vital role in the function of the RUNX2
protein, and the mutation carriers most commonly ex-
hibited childhood or juvenile onset of dental or skeletal
abnormalities, without neurological system involvement.
Notably, the patient in the present study initially pre-
sented with an upper extremity, predominant limb-
girdle myopathy. As extra-skeletal presentation, espe-
cially myopathy, is not common in patients with CCD,
we performed computerized English language literature
searches to identify case reports of myopathy or other
related neurological presentations in patients with CCD,
Fig. 3 Family pedigree and genetic analysis of the RUNX2 gene of the index patient with CCD. a Family pedigree of the index family. Black
symbols denote family members affected with CCD. The proband we described in the current study is marked with an arrow. m, mutated alleles;
wt, normal alleles. b Chromatograms of direct sequencing of the RUNX2 genomic sequence. Genetic analysis reveals a single nucleotide change
(c.674G > A, p.Arg225Gln, right panel) compared to the wild type sequence (left panel). The mutations identified in this study were located in the
indicated position
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making use of the following databases: PubMed (from
1975), and Ovid MEDLINE (from 1975). We used the
following main key words for searches: cleidocranial dys-
plasia, myopathy, weakness, atrophy and neurological
symptoms. For each selected article, the clinical descrip-
tions of study subjects were carefully reviewed. After
carefully reviewing more than 500 case studies, 13 stud-
ies reported their CCD patients present with muscle
weakness. Among these 15 reported cases, 2 were found
to carry FIG 4 gene mutation without RUNX2 gene mu-
tations, 1 patient was diagnosed as Ritscher-Schinzel
syndrome, 2 subjects’ weakness were secondary to cer-
vical myelopathy, 8 cases were lacking of detailed de-
scriptions of the weakness and the remaining 2 cases
presented with limb-girdle myopathy (Table 1). In those
cases, CCD was related to the c.G389A nonsense muta-
tion (p.W130X) and a mutation in the exon 2-intron
junction splice site (IVS2 + 2 T > A) [17]. The p.W130X
mutation produced a protein predicted to lack 390
amino acids, including part of the runt and PST do-
mains. The subject with the IVS2 + 2 T > A mutation
exhibited mild conductive deafness, in addition to myop-
athy. Histological and histochemical analyses of a muscle
biopsy specimen from the patient that carried the
p.W130X mutation revealed minor, non-specific, myo-
pathic changes [17]. These observations, combined with
our findings, suggested that muscular weakness was not
associated with mutations in any particular protein do-
main; thus, muscle weakness might be related to the loss
of function of the gene product. Recent studies have
shown that the expression of the RUNX2 transcription
factor may not be limited to osteoblasts and mesenchy-
mal stem cells; expression was also found in non-
osteoblast cells [5–7]. Several lines of evidence have in-
dicated that RUNX2 also plays an important role in adi-
pogenesis and skeletal muscle differentiation [18, 19].
RUNX2 stimulated the trans-differentiation of primary
skeletal myoblasts into a mineralizing osteoblastic
phenotype. RUNX2 also prevented myogenesis and myo-
tube formation via the suppression of MyoD and myo-
genin transcripts [19]. Thus, RUNX2 broadly modulates
cellular fates, including the fate of skeletal muscle cells.
Therefore, we hypothesized that mutations in the
RUNX2 gene may lead to damaging effects in muscle
cell maturation, which result in myopathy.
In summary, this case study described an uncommon
phenotype of late-onset limb-girdle distribution myop-
athy in a patient with CCD, associated with a RUNX2
p.Arg225Gln mutation. Considering the role of the
RUNX2 transcription factor in myogenesis, it is not sur-
prising that a carrier of the RUNX2 mutation presented
with extra-skeletal features. Our findings extended the
phenotypic spectrum of the RUNX2 p.R225Q mutation,
from typical dental/skeletal abnormalities to a limb-
girdle pattern of myopathy. Our results also remind cli-
nicians that patients with myopathies that present with
facial dysmorphism and dental or skeletal deformities
should be differentially diagnosed for CCD.
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